A Rare Case of Plasmablastic Myeloma After Renal Transplant.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Case study reveals aggressive plasmablastic myeloma post renal transplant, highlighting risks of posttransplant lymphoproliferative disorders.

Plasmablastic myeloma developed 56 months post renal transplant, leading to rapid health deterioration.
The patient presented symptoms including confusion and hypercalcemia, ultimately resulting in acute heart failure.
Bone marrow biopsy confirmed blastic morphology, with 80% of cells positive for CD138, indicative of plasma cell neoplasm.
Posttransplant lymphoproliferative disorders pose a serious risk in immunosuppressed patients, often with atypical progression.

Sulejman et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case study reveals aggressive plasmablastic myeloma post renal transplant, highlighting risks of posttransplant lymphoproliferative disorders.